Plasma glial fibrillary acidic protein is an early marker of Aβ pathology in Alzheimer’s disease
Joana B. Pereira, Shorena Janelidze, Ruben Smith, Niklas Mattsson-Carlgren, Sebastian Palmqvist, Henrik Zetterberg, Erik Stomrud, Nicholas J. Ashton, Kaj Blennow, Oskar Hansson
doi: https://doi.org/10.1101/2021.04.11.21255152
Joana B. Pereira
1Karolinska Institute, Lund University
Shorena Janelidze
2Lund University
Ruben Smith
3Clinical Memory Research Unit, Department of Clinical Sciences Malmo, Lund University, Sweden
Niklas Mattsson-Carlgren
2Lund University
Sebastian Palmqvist
3Clinical Memory Research Unit, Department of Clinical Sciences Malmo, Lund University, Sweden
Henrik Zetterberg
4University of Gothenburg
Erik Stomrud
3Clinical Memory Research Unit, Department of Clinical Sciences Malmo, Lund University, Sweden
Nicholas J. Ashton
4University of Gothenburg
Kaj Blennow
5Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Molndal, Sweden
Oskar Hansson
2Lund University
Data Availability
Anonymized data will be shared by request from a qualified academic investigator for the sole purpose of replicating procedures and results presented in the article and as long as data transfer is in agreement with EU legislation on the general data protection regulation and decisions by the Ethical Review Board of Sweden and Region Skane, which should be regulated in a material transfer agreement.
Posted April 14, 2021.
Plasma glial fibrillary acidic protein is an early marker of Aβ pathology in Alzheimer’s disease
Joana B. Pereira, Shorena Janelidze, Ruben Smith, Niklas Mattsson-Carlgren, Sebastian Palmqvist, Henrik Zetterberg, Erik Stomrud, Nicholas J. Ashton, Kaj Blennow, Oskar Hansson
medRxiv 2021.04.11.21255152; doi: https://doi.org/10.1101/2021.04.11.21255152
Plasma glial fibrillary acidic protein is an early marker of Aβ pathology in Alzheimer’s disease
Joana B. Pereira, Shorena Janelidze, Ruben Smith, Niklas Mattsson-Carlgren, Sebastian Palmqvist, Henrik Zetterberg, Erik Stomrud, Nicholas J. Ashton, Kaj Blennow, Oskar Hansson
medRxiv 2021.04.11.21255152; doi: https://doi.org/10.1101/2021.04.11.21255152
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (710)
- Anesthesia (201)
- Cardiovascular Medicine (2944)
- Dermatology (249)
- Emergency Medicine (440)
- Epidemiology (12750)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4586)
- Geriatric Medicine (419)
- Health Economics (729)
- Health Informatics (2918)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (426)
- Medical Ethics (115)
- Nephrology (469)
- Neurology (4359)
- Nursing (236)
- Nutrition (639)
- Oncology (2271)
- Ophthalmology (647)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1197)
- Primary Care Research (496)
- Public and Global Health (6944)
- Radiology and Imaging (1529)
- Respiratory Medicine (915)
- Rheumatology (438)
- Sports Medicine (385)
- Surgery (489)
- Toxicology (60)
- Transplantation (212)
- Urology (181)